Skip to main content

Rigel Pharmaceuticals Inc 10-K for FY2022

Rigel Pharmaceuticals Inc (RIGL)

10-K 2023-03-07 For: 2022-12-31
View Original
Added on April 06, 2026

About this 10-K

Rigel Pharmaceuticals Inc filed this 10-K on March 7, 2023, covering the fiscal year ended December 31, 2022 (FY2022).

Headline figures

Fiscal year ended December 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$120.24M
down 19.4% from $149.24M a year earlier
Net loss
$58.57M
compared with a net loss of $17.91M a year earlier
Diluted EPS
-$0.34
compared with -$0.11 a year earlier